{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:16:54Z","timestamp":1792783014190,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institutes of Health\/National Eye Institute","award":["National Institutes of Health\/National Eye Institute"],"award-info":[{"award-number":["National Institutes of Health\/National Eye Institute"]}],"id":[{"id":"https:\/\/ror.org\/03wkg3b53","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["U.S. Department of Veterans Affairs"],"award-info":[{"award-number":["U.S. Department of Veterans Affairs"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["U.S. Department of Veterans Affairs"],"award-info":[{"award-number":["U.S. Department of Veterans Affairs"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"DOI":"10.1007\/s10654-026-01471-6","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:40:59Z","timestamp":1792546859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Leukocytes and age-related macular degeneration"],"prefix":"10.1007","author":[{"given":"Nicolai","family":"Sandau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan R.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Peachey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tybjaerg-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Qvist","family":"Thomassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha K.","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4084-5027","authenticated-orcid":false,"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"1471_CR1","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","volume":"9","author":"JD Steinmetz","year":"2020","unstructured":"Steinmetz JD, Bourne RRA, Briant PS, Flaxman SR, Taylor HRB, Jonas JB, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2020;9:e144-60. https:\/\/doi.org\/10.1016\/S2214-109X(20)30489-7.","journal-title":"Lancet Glob Health"},{"key":"1471_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2020","unstructured":"Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2020;2:e106-16. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1.","journal-title":"Lancet Glob Health"},{"key":"1471_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-66014-7","volume-title":"Age-related macular degeneration: from clinic to genes and back to patient management","year":"2021","unstructured":"Chew EY, Swaroop A, editors. Age-related Macular Degeneration: From Clinic to Genes and Back to Patient Management. Cham: Springer International Publishing; 2021. https:\/\/doi.org\/10.1007\/978-3-030-66014-7."},{"key":"1471_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3233\/JAD-2011-101908","volume":"24","author":"K Kaarniranta","year":"2011","unstructured":"Kaarniranta K, Salminen A, Haapasalo A, Soininen H, Hiltunen M. Age-related macular degeneration (AMD): Alzheimer\u2019s disease in the eye? J Alzheimers Dis. 2011;24:615\u201331. https:\/\/doi.org\/10.3233\/JAD-2011-101908.","journal-title":"J Alzheimers Dis"},{"key":"1471_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","volume":"14","author":"RF Mullins","year":"2000","unstructured":"Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14:835\u201346.","journal-title":"FASEB J"},{"key":"1471_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.preteyeres.2011.02.004","volume":"30","author":"K Ohno-Matsui","year":"2011","unstructured":"Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer\u2019s disease. Prog Retin Eye Res. 2011;30:217\u201338. https:\/\/doi.org\/10.1016\/j.preteyeres.2011.02.004.","journal-title":"Prog Retin Eye Res"},{"key":"1471_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2016.04.003","volume":"54","author":"NG Lambert","year":"2016","unstructured":"Lambert NG, ElShelmani H, Singh MK, Mansergh FC, Wride MA, Padilla M, et al. Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res. 2016;54:64\u2013102. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.04.003.","journal-title":"Prog Retin Eye Res"},{"key":"1471_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/s1350-9462(01)00010-6","volume":"20","author":"GS Hageman","year":"2001","unstructured":"Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch\u2019s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705\u201332. https:\/\/doi.org\/10.1016\/s1350-9462(01)00010-6.","journal-title":"Prog Retin Eye Res"},{"key":"1471_CR9","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1073\/pnas.0408835103","volume":"103","author":"M Nozaki","year":"2006","unstructured":"Nozaki M, Raisler BJ, Sakurai E, Sarma JV, Barnum SR, Lambris JD, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA. 2006;103:2328\u201333. https:\/\/doi.org\/10.1073\/pnas.0408835103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1471_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ejhg.2008.140","volume":"17","author":"JA Fagerness","year":"2009","unstructured":"Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet. 2009;17:100\u20134. https:\/\/doi.org\/10.1038\/ejhg.2008.140.","journal-title":"Eur J Hum Genet"},{"key":"1471_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche LG, Igl W, Bailey JNC, Grassmann F, Sengupta S, Bragg-Gresham JL, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48:134\u201343. https:\/\/doi.org\/10.1038\/ng.3448.","journal-title":"Nat Genet"},{"key":"1471_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ng.2578","volume":"45","author":"LG Fritsche","year":"2013","unstructured":"Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, et al. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45:433\u20139. https:\/\/doi.org\/10.1038\/ng.2578. 439e1\u20132.","journal-title":"Nat Genet"},{"key":"1471_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng1750","volume":"38","author":"B Gold","year":"2006","unstructured":"Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet. 2006;38:458\u201362. https:\/\/doi.org\/10.1038\/ng1750.","journal-title":"Nat Genet"},{"key":"1471_CR14","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/ng2131","volume":"39","author":"JB Maller","year":"2007","unstructured":"Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet. 2007;39:1200\u20131. https:\/\/doi.org\/10.1038\/ng2131.","journal-title":"Nat Genet"},{"key":"1471_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1056\/NEJMoa072618","volume":"357","author":"JRW Yates","year":"2007","unstructured":"Yates JRW, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, et al. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med. 2007;357:553\u201361. https:\/\/doi.org\/10.1056\/NEJMoa072618.","journal-title":"N Engl J Med"},{"key":"1471_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/25158414211010550","volume":"13","author":"M Karahan","year":"2021","unstructured":"Karahan M, Hazar L, Erdem S, Ava S, Dursun ME, Demirta\u015f AA, et al. Is there a relationship between hematological inflammatory parameters and age-related macular degeneration? Ther Adv Ophthalmol. 2021;13:25158414211010550. https:\/\/doi.org\/10.1177\/25158414211010550.","journal-title":"Ther Adv Ophthalmol"},{"key":"1471_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/aos.14072","volume":"97","author":"S Niazi","year":"2019","unstructured":"Niazi S, Krogh Nielsen M, S\u00f8rensen TL, Subhi Y. Neutrophil-to-lymphocyte ratio in age-related macular degeneration: a systematic review and meta-analysis. Acta Ophthalmol. 2019;97:558\u201366. https:\/\/doi.org\/10.1111\/aos.14072.","journal-title":"Acta Ophthalmol"},{"key":"1471_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/erc.12.159","volume":"11","author":"T Bhat","year":"2013","unstructured":"Bhat T, Teli R, Rijal B, Bhat H, Raza M, Khoueiry P, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013;11:55\u20139. https:\/\/doi.org\/10.1586\/erc.12.159.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1471_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/aje\/kwk022","volume":"165","author":"A Shankar","year":"2007","unstructured":"Shankar A, Mitchell P, Rochtchina E, Tan J, Wang JJ. Association between circulating white blood cell count and long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Am J Epidemiol. 2007;165:375\u201382. https:\/\/doi.org\/10.1093\/aje\/kwk022.","journal-title":"Am J Epidemiol"},{"key":"1471_CR20","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.ophtha.2009.04.017","volume":"116","author":"M Yasuda","year":"2009","unstructured":"Yasuda M, Kiyohara Y, Hata Y, Arakawa S, Yonemoto K, Doi Y, et al. Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study. Ophthalmology. 2009;116:2135\u201340. https:\/\/doi.org\/10.1016\/j.ophtha.2009.04.017.","journal-title":"Ophthalmology"},{"key":"1471_CR21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1006\/exer.2001.1094","volume":"73","author":"LV Johnson","year":"2001","unstructured":"Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res. 2001;73:887\u201396. https:\/\/doi.org\/10.1006\/exer.2001.1094.","journal-title":"Exp Eye Res"},{"key":"1471_CR22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00018-019-03419-4","volume":"77","author":"V Behnke","year":"2020","unstructured":"Behnke V, Wolf A, Langmann T. The role of lymphocytes and phagocytes in age-related macular degeneration (AMD). Cell Mol Life Sci. 2020;77:781\u20138. https:\/\/doi.org\/10.1007\/s00018-019-03419-4.","journal-title":"Cell Mol Life Sci"},{"key":"1471_CR23","doi-asserted-by":"publisher","DOI":"10.22541\/au.172916161.12578845\/v1","volume-title":"Lymphocyte impact on age-related macular degeneration? A two-sample mendelian randomization study","author":"J Dai","year":"2024","unstructured":"Dai J, Zhou X, Zeng M, Sun Z, Luo W, Peng Q, et al. Lymphocyte impact on age-related macular degeneration? A two-sample mendelian randomization study. New York City: Authorea; 2024."},{"key":"1471_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep16754","volume":"5","author":"J Lechner","year":"2015","unstructured":"Lechner J, Chen M, Hogg RE, Toth L, Silvestri G, Chakravarthy U, et al. Alterations in circulating immune cells in neovascular age-related macular degeneration. Sci Rep. 2015;5:16754. https:\/\/doi.org\/10.1038\/srep16754.","journal-title":"Sci Rep"},{"key":"1471_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.18240\/ijo.2017.05.16","volume":"10","author":"EA Sengul","year":"2017","unstructured":"Sengul EA, Artunay O, Kockar A, Afacan C, Rasier R, Gun P, et al. Correlation of neutrophil\/lymphocyte and platelet\/lymphocyte ratio with visual acuity and macular thickness in age-related macular degeneration. Int J Ophthalmol. 2017;10:754\u20139. https:\/\/doi.org\/10.18240\/ijo.2017.05.16.","journal-title":"Int J Ophthalmol"},{"key":"1471_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/aos.13330","volume":"95","author":"Y Subhi","year":"2017","unstructured":"Subhi Y, Lykke S\u00f8rensen T. New neovascular age-related macular degeneration is associated with systemic leucocyte activity. Acta Ophthalmol. 2017;95:472\u201380. https:\/\/doi.org\/10.1111\/aos.13330.","journal-title":"Acta Ophthalmol"},{"key":"1471_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ajo.2021.03.010","volume":"227","author":"CC Xue","year":"2021","unstructured":"Xue CC, Cui J, Gao LQ, Zhang C, Dou HL, Chen DN, et al. Peripheral monocyte count and age-related macular degeneration. The Tongren health care study. Am J Ophthalmol. 2021;227:143\u201353. https:\/\/doi.org\/10.1016\/j.ajo.2021.03.010.","journal-title":"Am J Ophthalmol"},{"key":"1471_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2147\/OPTH.S121332","volume":"11","author":"SM Hector","year":"2017","unstructured":"Hector SM, S\u00f8rensen TL. Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration. Clin Ophthalmol. 2017;11:179\u201384. https:\/\/doi.org\/10.2147\/OPTH.S121332.","journal-title":"Clin Ophthalmol"},{"key":"1471_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12979-020-00205-w","volume":"17","author":"M Chen","year":"2020","unstructured":"Chen M, Yang N, Lechner J, Toth L, Hogg R, Silvestri G, et al. Plasma level of lipocalin 2 is increased in neovascular age-related macular degeneration patients, particularly those with macular fibrosis. Immun Ageing. 2020;17:35. https:\/\/doi.org\/10.1186\/s12979-020-00205-w.","journal-title":"Immun Ageing"},{"key":"1471_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12979-024-00440-5","volume":"21","author":"H Ojaghi","year":"2024","unstructured":"Ojaghi H, Poorsheykhian S, Najafi A, Iranpour S. The role of blood related inflammatory factors on age-related macular degeneration (AMD). Immun Ageing: I A. 2024;21:35. https:\/\/doi.org\/10.1186\/s12979-024-00440-5.","journal-title":"Immun Ageing: I A"},{"key":"1471_CR31","first-page":"153","volume":"2019","author":"CW Halladay","year":"2019","unstructured":"Halladay CW, Hadi T, Anger MD, Greenberg PB, Sullivan JM, Konicki PE, et al. Genetically-guided algorithm development and sample size optimization for age-related macular degeneration cases and controls in electronic health records from the VA Million Veteran Program. AMIA Summits Translational Sci Proc. 2019;2019:153\u201362.","journal-title":"AMIA Summits Translational Sci Proc"},{"key":"1471_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367. https:\/\/doi.org\/10.18637\/jss.v045.i03.","journal-title":"J Stat Softw"},{"key":"1471_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, Freeman C, Petkova D, Band G, Elliott LT, Sharp K, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139. https:\/\/doi.org\/10.1038\/s41586-018-0579-z.","journal-title":"Nature"},{"key":"1471_CR34","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.cell.2020.08.008","volume":"182","author":"D Vuckovic","year":"2020","unstructured":"Vuckovic D, Bao EL, Akbari P, Lareau CA, Mousas A, Jiang T, et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell. 2020;182:1214\u2013e123111. https:\/\/doi.org\/10.1016\/j.cell.2020.08.008.","journal-title":"Cell"},{"key":"1471_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/aje\/kwu283","volume":"181","author":"S Burgess","year":"2015","unstructured":"Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181:251\u201360. https:\/\/doi.org\/10.1093\/aje\/kwu283.","journal-title":"Am J Epidemiol"},{"key":"1471_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/gepi.22041","volume":"41","author":"JR Staley","year":"2017","unstructured":"Staley JR, Burgess S. Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization. Genet Epidemiol. 2017;41:341\u201352. https:\/\/doi.org\/10.1002\/gepi.22041.","journal-title":"Genet Epidemiol"},{"key":"1471_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature08151","volume":"460","author":"A Takeda","year":"2009","unstructured":"Takeda A, Baffi JZ, Kleinman ME, Cho WG, Nozaki M, Yamada K, et al. CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature. 2009;460:225\u201330. https:\/\/doi.org\/10.1038\/nature08151.","journal-title":"Nature"},{"key":"1471_CR38","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.4049\/jimmunol.169.5.2712","volume":"169","author":"A Menzies-Gow","year":"2002","unstructured":"Menzies-Gow A, Ying S, Sabroe I, Stubbs VL, Soler D, Williams TJ, et al. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers1. J Immunol. 2002;169:2712\u20138. https:\/\/doi.org\/10.4049\/jimmunol.169.5.2712.","journal-title":"J Immunol"},{"key":"1471_CR39","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1067\/mai.2000.108311","volume":"106","author":"T Fujisawa","year":"2000","unstructured":"Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K, et al. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol. 2000;106:507\u201313. https:\/\/doi.org\/10.1067\/mai.2000.108311.","journal-title":"J Allergy Clin Immunol"},{"key":"1471_CR40","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1089\/dna.2012.1786","volume":"31","author":"NK Sharma","year":"2012","unstructured":"Sharma NK, Prabhakar S, Gupta A, Singh R, Gupta PK, Gupta PK, et al. New biomarker for neovascular age-related macular degeneration: eotaxin-2. DNA Cell Biol. 2012;31:1618\u201327. https:\/\/doi.org\/10.1089\/dna.2012.1786.","journal-title":"DNA Cell Biol"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-026-01471-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-026-01471-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-026-01471-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:02:06Z","timestamp":1792591326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10654-026-01471-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":40,"alternative-id":["1471"],"URL":"https:\/\/doi.org\/10.1007\/s10654-026-01471-6","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have completed the ICMJE disclosure of interest form and the following was reported: SI reports grants from the National Institutes of Health\/National Eye Institute (NIH\/NEI) and from the U.S. Department of Veterans Affairs, as well as support for attending meetings and\/or travel from NIH\/NEI and the Ryan Institute for Macular Research. NP reports support for the present manuscript from the U.S. Department of Veterans Affairs Office of Research and Development, as well as support for attending meetings and\/or travel from the Cleveland Clinic. The remaining authors report no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}